Eric Vallabh Minikel, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prion Diseases | 16 | 2024 | 99 | 5.220 |
Why?
|
Prions | 9 | 2024 | 177 | 2.290 |
Why?
|
Oligonucleotides, Antisense | 4 | 2023 | 461 | 1.570 |
Why?
|
Genes, Essential | 2 | 2020 | 185 | 0.790 |
Why?
|
Neurodegenerative Diseases | 5 | 2022 | 1094 | 0.740 |
Why?
|
Age of Onset | 2 | 2019 | 3346 | 0.670 |
Why?
|
Drug Discovery | 3 | 2024 | 1068 | 0.640 |
Why?
|
Penetrance | 3 | 2019 | 386 | 0.620 |
Why?
|
Drug Approval | 1 | 2024 | 821 | 0.550 |
Why?
|
Anticipation, Genetic | 1 | 2014 | 5 | 0.490 |
Why?
|
Benzimidazoles | 1 | 2020 | 864 | 0.480 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 742 | 0.470 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2014 | 92 | 0.450 |
Why?
|
Genetic Diseases, Inborn | 2 | 2016 | 606 | 0.430 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2830 | 0.410 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2204 | 0.400 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8055 | 0.350 |
Why?
|
Gene Frequency | 4 | 2024 | 3626 | 0.350 |
Why?
|
Bicycling | 1 | 2011 | 177 | 0.340 |
Why?
|
Environment Design | 1 | 2011 | 174 | 0.340 |
Why?
|
Transportation | 1 | 2011 | 217 | 0.330 |
Why?
|
Genetic Variation | 6 | 2020 | 6611 | 0.300 |
Why?
|
Safety | 1 | 2011 | 1161 | 0.270 |
Why?
|
Exons | 2 | 2024 | 2395 | 0.270 |
Why?
|
Accidents, Traffic | 1 | 2011 | 819 | 0.250 |
Why?
|
Heterozygote | 5 | 2024 | 2798 | 0.210 |
Why?
|
Brain | 6 | 2024 | 27453 | 0.210 |
Why?
|
RNA Splice Sites | 1 | 2024 | 213 | 0.210 |
Why?
|
Urban Population | 1 | 2011 | 2046 | 0.210 |
Why?
|
PrPC Proteins | 1 | 2021 | 35 | 0.190 |
Why?
|
Multiple Sclerosis | 1 | 2016 | 3250 | 0.190 |
Why?
|
Cerebrospinal Fluid | 1 | 2023 | 545 | 0.170 |
Why?
|
Oligonucleotides | 1 | 2023 | 563 | 0.170 |
Why?
|
Mutation | 6 | 2020 | 30266 | 0.170 |
Why?
|
Gene Silencing | 2 | 2024 | 1505 | 0.170 |
Why?
|
Sample Size | 2 | 2020 | 848 | 0.160 |
Why?
|
Tissue Distribution | 1 | 2023 | 2298 | 0.160 |
Why?
|
Dependovirus | 1 | 2024 | 721 | 0.160 |
Why?
|
Central Nervous System Diseases | 1 | 2023 | 521 | 0.160 |
Why?
|
Probability | 1 | 2024 | 2483 | 0.160 |
Why?
|
Consanguinity | 1 | 2020 | 460 | 0.150 |
Why?
|
Treatment Failure | 1 | 2024 | 2664 | 0.150 |
Why?
|
Automation | 1 | 2020 | 589 | 0.140 |
Why?
|
Macaca fascicularis | 1 | 2019 | 913 | 0.140 |
Why?
|
Treatment Outcome | 1 | 2024 | 65480 | 0.140 |
Why?
|
Mice | 7 | 2024 | 82072 | 0.140 |
Why?
|
Jews | 1 | 2018 | 359 | 0.130 |
Why?
|
Genome, Human | 3 | 2020 | 4456 | 0.130 |
Why?
|
Genotype | 2 | 2022 | 13048 | 0.130 |
Why?
|
Autoantigens | 1 | 2020 | 891 | 0.130 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1608 | 0.130 |
Why?
|
Rare Diseases | 2 | 2018 | 631 | 0.120 |
Why?
|
Humans | 31 | 2024 | 768970 | 0.120 |
Why?
|
RNA | 2 | 2023 | 2727 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3813 | 0.120 |
Why?
|
Homozygote | 1 | 2020 | 1780 | 0.120 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1340 | 0.120 |
Why?
|
Alleles | 2 | 2024 | 6901 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 4 | 2024 | 18068 | 0.120 |
Why?
|
Animals | 11 | 2024 | 169335 | 0.120 |
Why?
|
Histones | 1 | 2024 | 2603 | 0.110 |
Why?
|
tau Proteins | 2 | 2024 | 2146 | 0.110 |
Why?
|
Craniosynostoses | 1 | 2017 | 416 | 0.100 |
Why?
|
Pyrazoles | 1 | 2023 | 2029 | 0.100 |
Why?
|
Artifacts | 1 | 2020 | 1942 | 0.090 |
Why?
|
Autoantibodies | 1 | 2020 | 2120 | 0.090 |
Why?
|
Databases, Genetic | 4 | 2020 | 1758 | 0.090 |
Why?
|
Genome | 1 | 2019 | 1754 | 0.090 |
Why?
|
Acceleration | 1 | 2011 | 190 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3782 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4432 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20245 | 0.080 |
Why?
|
Cell Line | 2 | 2020 | 15604 | 0.080 |
Why?
|
Motor Vehicles | 1 | 2011 | 280 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 599 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6547 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1887 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2748 | 0.070 |
Why?
|
Cardiomyopathies | 2 | 2017 | 2057 | 0.070 |
Why?
|
California | 1 | 2011 | 1443 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22379 | 0.070 |
Why?
|
Pedigree | 1 | 2014 | 4545 | 0.070 |
Why?
|
Risk Factors | 4 | 2021 | 74976 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4785 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.060 |
Why?
|
Crohn Disease | 1 | 2018 | 2294 | 0.060 |
Why?
|
Choice Behavior | 1 | 2011 | 848 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12562 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12174 | 0.050 |
Why?
|
Research Design | 1 | 2019 | 6214 | 0.050 |
Why?
|
Rats | 1 | 2019 | 23786 | 0.050 |
Why?
|
Genetic Testing | 1 | 2016 | 3591 | 0.050 |
Why?
|
5' Untranslated Regions | 1 | 2024 | 255 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11932 | 0.050 |
Why?
|
Male | 10 | 2024 | 365203 | 0.050 |
Why?
|
Time Factors | 1 | 2024 | 40261 | 0.050 |
Why?
|
Female | 11 | 2024 | 397515 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2024 | 564 | 0.050 |
Why?
|
Phenotype | 5 | 2020 | 16731 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2020 | 22296 | 0.050 |
Why?
|
Neurofilament Proteins | 1 | 2024 | 337 | 0.050 |
Why?
|
Introns | 1 | 2024 | 969 | 0.050 |
Why?
|
Computer Simulation | 1 | 2014 | 6291 | 0.050 |
Why?
|
Transgenes | 1 | 2024 | 1016 | 0.040 |
Why?
|
Protein Structure, Quaternary | 1 | 2021 | 426 | 0.040 |
Why?
|
Cohort Studies | 3 | 2020 | 41808 | 0.040 |
Why?
|
Proteins | 1 | 2015 | 6011 | 0.040 |
Why?
|
Young Adult | 2 | 2019 | 60131 | 0.040 |
Why?
|
Primates | 1 | 2022 | 522 | 0.040 |
Why?
|
Models, Statistical | 1 | 2014 | 5110 | 0.040 |
Why?
|
Adult | 6 | 2024 | 223851 | 0.040 |
Why?
|
RNA Splicing | 1 | 2024 | 905 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59739 | 0.040 |
Why?
|
Child | 2 | 2019 | 80960 | 0.040 |
Why?
|
Adolescent | 2 | 2019 | 89244 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2517 | 0.040 |
Why?
|
Middle Aged | 5 | 2024 | 223737 | 0.040 |
Why?
|
Aged | 4 | 2020 | 171786 | 0.040 |
Why?
|
alpha-Synuclein | 1 | 2024 | 774 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2021 | 1952 | 0.030 |
Why?
|
Facies | 1 | 2017 | 224 | 0.030 |
Why?
|
Polyradiculoneuropathy | 1 | 2016 | 65 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2018 | 473 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14794 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2016 | 148 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2019 | 959 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 789 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3076 | 0.030 |
Why?
|
Endonucleases | 1 | 2016 | 371 | 0.030 |
Why?
|
Genetics, Population | 1 | 2018 | 944 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1251 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2016 | 818 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 1742 | 0.030 |
Why?
|
Longevity | 1 | 2020 | 1077 | 0.030 |
Why?
|
Lymphocytes | 1 | 2020 | 2614 | 0.020 |
Why?
|
Kinetics | 1 | 2019 | 6332 | 0.020 |
Why?
|
Haplotypes | 1 | 2018 | 2725 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18354 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 2016 | 750 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 1682 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2023 | 9565 | 0.020 |
Why?
|
Phagocytosis | 1 | 2016 | 1530 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6512 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2015 | 1105 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12801 | 0.020 |
Why?
|
Gene Deletion | 1 | 2016 | 2674 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3449 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2041 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4124 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9344 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13674 | 0.020 |
Why?
|
Trans-Activators | 1 | 2016 | 2858 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1891 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2020 | 2895 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2014 | 81903 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12806 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12873 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12430 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3562 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3671 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14752 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2016 | 17629 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15879 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5801 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9549 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16053 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14201 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36556 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15661 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42683 | 0.010 |
Why?
|